Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
Alliot
C
C
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D018579:Patient Selection; D011379:Prognosis; D015203:Reproducibility of Results; D016896:Treatment Outcome
D003841:Deoxycytidine; D016685:Mitomycin; D000069287:Capecitabine; D005472:Fluorouracil